𝔖 Bobbio Scriptorium
✦   LIBER   ✦

P-8-10 Safety and tolerance of ENA 713 in Alzheimer's disease (AD)

✍ Scribed by N.R. Cutler; J.J. Sramek; R. Anand


Book ID
119176395
Publisher
Elsevier Science
Year
1995
Tongue
English
Weight
277 KB
Volume
5
Category
Article
ISSN
0924-977X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Safety and tolerability of rivastigmine
✍ Jason T. Olin; Vinod Bhatnagar; Patricio Reyes; Barbara Koumaras; Xiangyi Meng; πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 139 KB πŸ‘ 2 views

## Abstract ## Objective Rivastigmine, a dual cholinesterase inhibitor (ChEI), is widely approved for the symptomatic treatment of both mild‐to‐moderate Alzheimer's disease (AD) and Parkinson's disease dementia. Orally administered ChEIs may be associated with gastrointestinal (GI) side effects an